Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | THRA | P10827 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.49 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.49 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.49 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.49 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.49 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.49 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | RARB | P10826 | 1/20 | 0.47 |
| ▸ | PLK1 | P53350 | 1/20 | 0.47 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL416529 | 0.94 | RARB (0.56) | ALDH1A1HPGDHSD17B10SMN1; SMN2CA2 | |
| SCHEMBL4454097 | 0.94 | ALDH1A1 (0.47) | ALDH1A1HPGDHSD17B10SMN1; SMN2CA2 | |
| SCHEMBL847304 | 0.94 | ALDH1A1 (0.53) | ALDH1A1HPGDHSD17B10SMN1; SMN2CA2 | |
| SCHEMBL6067892 | 0.92 | ESR1 (0.57) | ALDH1A1HSD17B10LMNATHRATHRB | |
| SCHEMBL20594193 | 0.92 | ESR1 (0.57) | ALDH1A1HSD17B10LMNATHRATHRB | |
| SCHEMBL2120077 | 0.92 | ESR1 (0.57) | ALDH1A1HSD17B10LMNATHRATHRB | |
| SCHEMBL1884477 | 0.92 | ESR1 (0.57) | ALDH1A1HSD17B10LMNATHRATHRB | |
| SCHEMBL11811560 | 0.92 | ESR1 (0.57) | ALDH1A1HSD17B10LMNATHRATHRB | |
| SCHEMBL177373 | 0.92 | ESR1 (0.57) | ALDH1A1HSD17B10LMNATHRATHRB | |
| SCHEMBL9026740 | 0.92 | ESR1 (0.57) | ALDH1A1HSD17B10LMNATHRATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1406 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117980454-B | Aldehyde composition | 三菱瓦斯化学株式会社 | 2026-05-19 | — | — | CN | claimed |
| EP-4410768-B1 | ALDEHYDE COMPOSITION | MITSUBISHI GAS CHEMICAL CO (JP) | 2025-11-26 | — | — | EP | claimed |
| US-20240391859-A1 | ALDEHYDE COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-11-28 | — | — | US | claimed |
| EP-4410768-A1 | ALDEHYDE COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-08-07 | — | — | EP | claimed |
| CN-118271331-A | Gelsemin derivatives, synthesis method and application thereof in inhibiting tumor cell proliferation | 赣江中药创新中心 | 2024-07-02 | — | — | CN | claimed |
| CN-117980454-A | Aldehyde composition | 三菱瓦斯化学株式会社 | 2024-05-03 | — | — | CN | claimed |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | OHIO STATE INNOVATION FOUNDATION | 2024-02-01 | — | — | US | claimed |
| WO-2023053860-A1 | ALDEHYDE COMPOSITION | 三菱瓦斯化学株式会社 | 2023-04-06 | — | — | WO | claimed |
| US-11576946-B2 | Peptidyl inhibitors of calcineurin-NFAT interaction | OHIO STATE INNOVATION FOUNDATION (US) | 2023-02-14 | — | — | US | claimed |
| CN-110085879-B | Co9S8Sulfur-nitrogen co-doped carbon composite material and preparation method thereof | 中国科学院山西煤炭化学研究所 | 2021-12-24 | — | — | CN | claimed |
| EP-0943660-A1 | DITHIOCARBONATE COMPOSITION | Kyowa Yuka Co., Ltd. (JP) | 1999-09-22 | — | — | EP | claimed |
| US-5919403-A | POLYESTERS | EASTMAN CHEMICAL COMPANY (US) | 1999-07-06 | — | — | US | claimed |
| WO-1998034111-A1 | TRICYCLIC TETRAHYDROQUINOLINE DERIVATIVES AND TRICYCLIC TETRAHYDROQUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| WO-1998034115-A1 | 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| US-5201936-A | Substituted thieno[3,2-b]pyran-5,7-diones | BAYER AKTIENGESELLSCHAFT (DE) | 1993-04-13 | — | — | US | claimed |
| EP-0483582-A1 | Thieno[3,2-b]pyranones, process for their preparation, intermediates, their use in combatting parasites, their use as herbicides and plantgrowth regulators | BAYER AG (DE) | 1992-05-06 | — | — | EP | claimed |
| EP-0151593-B1 | ENZYME DERIVATIVES | BEECHAM GROUP PLC (GB) | 1989-02-22 | — | — | EP | claimed |
| US-4604285-A | ANTICOAGULANT | BEECHAM GROUP P.L.C. (GB) | 1986-08-05 | — | — | US | claimed |
| EP-0151593-A1 | ENZYME DERIVATIVES. | BEECHAM GROUP PLC (GB) | 1985-08-21 | — | — | EP | claimed |
| WO-1985000521-A1 | ENZYME DERIVATIVES | BEECHAM GROUP P.L.C. (GB) | 1985-02-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240391859-A1 | ALDEHYDE COMPOSITION | ALDH1A1, ALDH2, ALDH1B1 | ALDH1A1 1/4885HPGD 595/4885HSD17B10 42/4885 |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | CHP1, NFATC1, PPP3R1 | ALDH1A1 4851/4885HPGD 4160/4885HSD17B10 3605/4885 |
| US-11576946-B2 | Peptidyl inhibitors of calcineurin-NFAT interaction | CHP1, NFATC1, PPP3R1 | ALDH1A1 4851/4885HPGD 4160/4885HSD17B10 3605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.